載入...
Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy
Lymphodepletion chemotherapy with CD19-targeted chimeric antigen receptor–modified T (CAR-T)-cell immunotherapy is a novel treatment for refractory or relapsed B-cell malignancies. Infectious complications of this approach have not been systematically studied. We evaluated infections occurring betwe...
Na minha lista:
| 發表在: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5755046/ https://ncbi.nlm.nih.gov/pubmed/29038338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-793760 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|